Design Controls for Medical Device Data Systems

by | Mar 5, 2021 | Data, Design Controls, FDA, Medical Devices, Quality

Medical Device Data Systems (MDDS) are hardware or software products that are intended to transfer, store, convert document forms and display medical device data. MDDS on its own does not modify the data or control any functions of the connected medical device and may or may not be used in active patient monitoring.

As per the requirements of section 520(o)(1)(D) of the Federal Food, Drug, and Cosmetic Act:1

  • Software functions that are solely intended to transfer, store, convert formats, and display medical device data or medical imaging data, are not devices and are not subject to FDA regulatory requirements applicable to devices. The FDA describes these software functions as “Non-Device-MDDS.”
  • Hardware functions that are solely intended to transfer, store, convert formats, and display medical device data or results are “Device-MDDS.”

Some examples of non-device MDDS include software systems that:

  • Store patient data, such as blood pressure readings, for review at a later time;
  • Convert digital data generated by a pulse oximeter into a format that can be printed; and
  • Display a previously stored electrocardiogram for a particular patient.

 

Though a software MDDS does not have to comply with the FDA regulatory requirements there are some activities which a manufacturer must consider when incorporating an MDDS in a medical device. Software within a medical device must be considered as any other off-the-shelf component of the device and included in the risk file of the device. MDDS may have an impact on the safety and efficacy of the medical device as a whole and thus has an impact on patient safety. Furthermore, if you are a supplier of an MDDS component, developing your software system in compliance with good software development practices will show a good faith effort to your customers and regulatory authorities.

In my opinion, it is always better to go above and beyond to stay in compliance than to face the repercussions later. Even if design controls do not apply to non-device MDDS, following design controls will only ensure that your product development activities are in alignment with the expectations of your customers and patients. EMMA International can assist you to develop a robust and compliance design controls program. Call us today at +1 248-987-4497 or email us at info@emmainternational.com to know more about our proprietary methodology.


1FDA(2019) Medical Device Data Systems retrieved on 03/02/2021 from https://www.fda.gov/medical-devices/general-hospital-devices-and-supplies/medical-device-data-systems

Nikita Angane

Nikita Angane

Solutions Delivery Specialist - Ms. Angane is a Bioengineering graduate with experience in medical device commercialization, product development, quality system compliance and regulatory affairs. Her portfolio includes working on medical devices, combination products, and pharmaceuticals. As a Solutions Delivery Specialist at EMMA International, she offers her expertise to help our clients achieve an effective and sustainable quality system, and develop regulatory strategies for market access and compliance of new products in the US and international markets. Ms. Angane earned a Bachelor of Engineering in Biomedical Engineering from the University of Mumbai, India and an M.S. in Bioengineering from University of Illinois at Chicago.

More Resources

Pattern Recognition as a Quality Superpower

Pattern Recognition as a Quality Superpower

There are always new ways and reasons to apply pattern recognition to quality improvement. Better ensuring patient outcomes in health care facilities and improving accuracy for medical diagnoses are two such frontiers.
Record Control for a Regulated World

Record Control for a Regulated World

In a regulated industry, the prevailing posture of regulatory representatives, in my experience, has been “Show me proof.” In fact, the philosophy I’ve heard repeated by regulators is “If it wasn’t documented, it didn’t happen.”
EU MDR SSCP’s: The Importance of Readability

EU MDR SSCP’s: The Importance of Readability

Among many of the new requirements that EU MDR has introduced, the Summary of Safety and Clinical Performance (SSCP) is certainly one of the more confusing ones for many firms. SSCP’s are required for implantable and Class III devices under EU MDR and is intended to be a public document summarizing important safety and clinical performance information about the device.

Ready to learn more about working with us?

Pin It on Pinterest

Share This